Erlotinib treatment induces cytochrome P450 3A activity in non-small cell lung cancer patients.
Erlotinib treatment induces cytochrome P450 3A activity in non-small cell lung cancer patients. — المؤلف: Svedberg, Anna — British journal of clinical pharmacology 20200824
- المؤلف
- Svedberg, Anna
- النشر
- British journal of clinical pharmacology 20200824
- الوصف
- 1704-1709 p.
- الموضوعات
- Aged؛ Aged, 80 and over؛ Carcinoma, Non-Small-Cell Lung؛ Cytochrome P-450 CYP3A؛ Drug Interactions؛ Drug Monitoring؛ Erlotinib Hydrochloride؛ Female